Myomo, Inc.
(NYSE Amex Equities : MYO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Distribution Services » Medical Distributors
symbolcompany%chnglast%shortavg$volume
MCKMcKesson Corp. -0.61%334.382.9%$393.85m
ABCAmerisourceBergen Corp. 0.65%156.828.0%$297.96m
CAHCardinal Health, Inc. -0.79%57.562.8%$164.96m
HSICHenry Schein, Inc. 0.40%85.961.7%$83.94m
HLFHerbalife Nutrition Ltd. 1.64%22.3625.2%$37.90m
OMIOwens & Minor, Inc. 2.77%35.4512.5%$30.65m
PDCOPatterson Cos., Inc. 1.34%31.8711.5%$20.83m
YI111, Inc. 20.76%1.920.0%$0.61m
MOHOECMOHO Ltd. 3.48%0.180.0%$0.09m
JWELJowell Global Ltd. 2.18%2.340.0%$0.07m
MYOMyomo, Inc. 2.80%2.200.0%$0.05m

Company Profile

Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. It offers MyoPro, an upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Boston, MA.